Adhansia XR Label Update; ADHD and Physical Ailments; 'Internet Gaming Disorder'
(MedPage Today) -- FDA gave the greenlight to Adlon Therapeutics to update their label for methylphenidate hydrochloride extended-release capsules CII (Adhansia XR) to include recent data demonstrating rapid (within 1 hour) and sustained (lasting...
Read more »